NOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC) Patients: TONIC-3 Trial
Conditions: Metastatic Breast Cancer Interventions: Drug: Tiragolumab; Drug: Atezolizumab; Drug: Ipilimumab Sponsors: The Netherlands Cancer Institute; Hoffmann-La Roche Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Immunotherapy | Netherlands Health | Research | Yervoy